Development of the rat model of lapatinib-induced diarrhoea

Files

hdl_95947.pdf (1.3 MB)
  (Published version)

Date

2014

Authors

Bowen, J.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Scientifica, 2014; 2014:194185-1-194185-6

Statement of Responsibility

Joanne M. Bowen

Conference Name

Abstract

Targeted therapy of cancer is often associated with clinically significant diarrhoea; however, the mechanisms underpinning this adverse effect are currently unknown. Diarrhoea following treatment with tyrosine kinase inhibitors (TKIs) of EGFR is particularly troublesome. Until recently, understanding of EGFR TKI-induced diarrhoea has been limited to clinical observation. However, our group has recently developed the first rat model of EGFR TKI-induced diarrhoea. This paper reviews the published and unpublished findings.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2014 Joanne M. Bowen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

License

Grant ID

Call number

Persistent link to this record